The 30-day special legislative session is set to officially conclude on August 19. However, many Democratic lawmakers are currently out of the state, which means the House cannot conduct business without a quorum. As a result, House Speaker Dustin Burrows (R) announced that if a quorum is not present, the House will adjourn sine die on August 15. If this occurs, Gov. Greg Abbott (R) has pledged to immediately call for another special session.
Also in Texas, at the August 8 meeting, the Board of Pharmacy adopted rules on prescription delivery, allowing certain prescription drugs to be delivered by drones and contract carriers. The rules take effect on the date that they are published in the Texas Register.
Also in Texas, the Board of Pharmacy members elected HEB pharmacist Donna Montemayor to serve at Vice President of the Board and Donnie Lewis, RPh to serve as Treasurer.
Also in Texas, on September 1, the Health and Human Services Commission's (HHSC) Vendor Drug Program (VDP) will begin identifying some drugs with temporary non-preferred (TNP) status. TNP drugs are new-to-market drugs available on the Medicaid formulary but that have not yet been reviewed by the state's Drug Utilization Review Board for a preferred drug list status, either preferred or non-preferred.
Also in Texas, HHSC is encouraging pharmacies to enroll in Healthy Texas Women (HTW), offering women's health and family planning services at no cost to eligible Texans. More information on the program can be found on the HTW website. Pharmacies can enroll as participating HTW providers when completing the enrollment process through the Texas Medicaid & Healthcare Partnership's (TMHP's) Provider Enrollment and Management System (PEMS). Pharmacies are automatically enrolled in HTW when completing the Medicaid enrollment unless the pharmacy unchecks the HTW participation box. The HTW Provider Certification and Attestation form does not apply to pharmacies. See the TMHP PEMS website for enrollment information.
Also in Texas, HHSC removed the non-preferred status from the generic methylphenidate patch products on the preferred drug list effective August 11, as a result of manufacturer-reported backorders due to supply shortages.
Finally in Texas, HHSC published an update to the Clinical Prior Authorization Assistance Chart (PDF). HHSC requires managed care organizations (MCOs) to implement specific clinical prior authorizations for clients enrolled in managed care. Usage of other clinical prior authorizations will vary between MCOs at the discretion of each MCO. Refer to the Pharmacy Provider Procedure Manual for more information about required clinical prior authorizations in managed care.
For more information, contact NACDS’ Mary Staples at 817-442-1155.